Galleri
$950 - A cancer screening tool that allows us to look for multiple cancers with a blood sample. This cancer screening test, called Galleri, allows us to look for a common cancer signal across multiple cancers and then can further specify where a positive signal may be originating from. Staying up to date with cancer screening is important and this test does not replace other forms of screening (colonoscopy, mammogram, etc) but is in addition to the routine screening to increase the odds of finding cancer in the early stages when they are most treatable. If interested, please schedule a visit so we can discuss the risks and benefits of the test and decide if obtaining the test is what’s best for you. The cost is around $950 and the Galleri company has financing available.
HART CADhs
$199 - A low cost, low risk, highly accurate (86% accuracy), cardiac diagnostic blood test for scoring known and unknown obstructive coronary artery disease. This test was also developed and validated in collaboration with researchers at Massachusetts General Hospital. This test utilizes Artificial intelligence to select and combine a panel of three proteins: High sensitivity Troponin, Kidney Injury molecule and Adiponectin to provide a personalized score for each patient. It is more accurate (86%) than other standard care tests including stress test, genetic tests, and coronary artery calcium scores. No fasting is required to take this test. Your score and individual protein values from the test will help your physician detect any underlying heart disease and create a personalized treatment plan for you. This test is also covered by Medicare, Medicare advantage and has affordable self-pay options at $199 or $328, if obtained with the HART CVE below.
HART CVE
$199 - A low cost, low risk, highly accurate (86% accuracy) and only marketed cardiac prognostic blood test for scoring one-year (and up to four-year) risk of heart attack, stroke, cardiac death, and all-cause death. This test was developed and validated in collaboration with researchers at Massachusetts General Hospital This test utilizes Artificial intelligence to select and combine a panel of four proteins: NT-proBNP, Kidney injury molecule, Osteopontin, and Tissue Inhibitor of Metalloproteinases to provide a personalized score for each patient. It is more accurate (86%) than other standard of care tests including stress test, genetic tests, and coronary artery calcium scores. No fasting is required to take this test. Your score and individual protein values from the test will help your physician detect any underlying heart disease and create a personalized treatment plan for you. This test is covered by Medicare, Medicare advantage and has affordable self-pay options at at $199 or $328, if obtained with the HART CADhs above.